Abata Therapeutics to Present at Upcoming Investor and Industry Events...

Your unfiltered news center. ®

The world you see depends upon the news you get. ®

HOME

ARTS

RSS

Today's Date: April 23, 2024

JBG SMITH Releases 2024 Sustainability Report • TULU 2024 World Indigenous Tourism Summit Opens in Kaohsiung, Taiwan, Gathering 27 Countries to Focus on "Indigenous Cultures an • 2023 Sustainability Report Demonstrates Canfor and Canfor Pulp's Continued ESG Performance • Resilient Waters Fund Wins the 2024 Kellogg-Morgan Stanley Sustainable Investing Challenge • iSun, Inc. Announces Restructuring of Executive Team • Seagate Drives Progress on Its Renewable Energy and Circularity Programs • Vasta Platform Limited to Report First Quarter 2024 Financial Results on May 08, 2024 • Quaker Houghton Releases its 2023 Sustainability Report • FPT to Shape the Future of AI and Cloud on a Global Scale in Collaboration with NVIDIA • The 2024 Japan Prize Award Ceremony Is Held with Their Majesties the Emperor and Empress of Japan in Attendance • BOARDWALK RELEASES 2023 ESG REPORT • New novel explores love, loss and triumph through the eyes of a first-generation Latina lawyer • Alterra Mountain Company Releases Its 2023 Impact Report • 2023 Sustainability Report Demonstrates Canfor Pulp and Canfor's Continued ESG Performance • The Tokyo Station Hotel Expands Carbon Neutral Stay Program to All Rooms to Help Achieve Sustainable World • JA Solar Joins United Nations Global Compact's "Forward Faster" Initiative • Coke Florida Celebrates Earth Day with Statewide Sustainability and Conservation Activities • AUSTRALIAN BATTERY MATERIALS INNOVATOR ANNOUNCES US EXPANSION • Green Seal Releases 2024 Impact Report Showing Meaningful Plastic, Water, Carbon Savings from Certified Products • First of its Kind Partnership Delivers a Waste Heat to Power Project That Will Reduce the University of Dayton’s Carbon Fo

Abata Therapeutics to Present at Upcoming Investor and Industry Events in June

BOSTON , May 31 /Businesswire/ - Abata Therapeutics, a company focused on translating the biology of regulatory T cells (Tregs) into transformational medicines for patients living with severe autoimmune and inflammatory diseases, today announced that Samantha Singer, M.S., M.B.A., president, and chief executive officer will present at the following events in June:

Jefferies Global Healthcare Conference: Presentation on Wednesday, June 7, 2023, at 3:30 p.m. ET in New York, NY.
World Medical Innovation Forum: Panel discussion titled “The Innovation Gap: Old Dog, New Tricks – Reprogramming the Immune System” on Wednesday, June 14, 2023, at 9:15 a.m. ET in Boston, MA.

About Abata Therapeutics

Abata Therapeutics is focused on translating the biology of regulatory T cells (Tregs) into transformational medicines for patients with severe autoimmune and inflammatory diseases. Founded by pioneers in Treg biology, TCR and antigen discovery, disease pathogenesis, and molecular and imaging biomarkers, Abata has developed a differentiated product engine to create engineered Treg cell therapies that are tissue-specific, robust, and durable. Abata’s lead program is in progressive multiple sclerosis (MS), and its second program is in type 1 diabetes - both indications are tissue-specific autoimmune diseases with substantial unmet needs, supporting a strong rationale for Abata’s Treg approach. The company was launched in 2021 by Third Rock Ventures, with participation from a diverse syndicate of investors, including ElevateBio, Lightspeed Venture Partners, Invus, Samsara BioCapital, and the JDRF T1D Fund. Abata is based in Watertown, Mass. Please visit abatatx.com or follow us on Twitter or LinkedIn for more information.